QTRX News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

QT

Volume

280.42K

Next Earnings

November 9th

Loading chart

QT

QTRXQuanterix Corporation Common Stock

QTRX

Pay with—

Available Balance0.00

QT

Mkt Cap

$145.2M

Volume

280.42K

Next Earnings

November 9th

Chart Financials Earnings News About Insider Filings

Global Alzheimer’s Disease Biomarker Market Poised for Phenomenal Expansion at a Growth Rate of ~9% by 2034 | DelveInsightThe global Alzheimer's disease biomarker market is projected to grow from USD 2.2 billion in 2025 to USD 4.7 billion by 2034, driven by rising disease prevalence, aging populations, and advancements in blood-based biomarkers like phosphorylated tau and amyloid-beta assays. North America leads the market with 41% share, while Asia-Pacific is the fastest-growing region. Recent FDA clearances and expanded laboratory testing availability are accelerating market adoption.GlobeNewswire Inc. · Sep 22, 2026

Global Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays with 68% Market ShareThe global multiplex assays market is projected to grow from US$6.8 billion in 2025 to US$12.4 billion by 2030, at a 12.8% CAGR. North America leads with 34% market share, while Asia Pacific is the fastest-growing region at 15.5% CAGR. Consumables dominate with 68% market share, and protein multiplex assays hold 42%. Growth is driven by precision medicine, companion diagnostics, and laboratory automation.GlobeNewswire Inc. · Sep 4, 2026

Global Blood-Based Biomarkers Market to Witness Upsurge in Growth at a CAGR of ~9% by 2034 | DelveInsightThe global blood-based biomarkers market is projected to grow from USD 8.5 billion in 2025 to USD 18.5 billion by 2034, driven by increasing demand for non-invasive diagnostics, rising chronic disease prevalence, and advances in genomics and liquid biopsy technologies. North America leads with 44% market share, while Asia-Pacific shows fastest growth. Key players include Roche, Abbott, Siemens Healthineers, and Thermo Fisher Scientific.GlobeNewswire Inc. · Aug 27, 2026

New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer BiotechsThe article discusses the growing cancer treatment market, with a focus on companies like Oncolytics Biotech, Akoya Biosciences, Quanterix, TScan Therapeutics, and Arcellx. It highlights new data and collaborations that signal a turning point for precision-driven cancer biotechs.Benzinga · May 23, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of AKYA, WTMA, PLYA, QTRX to Act NowMonteverde & Associates PC, a class action law firm, is investigating several proposed mergers, including Akoya Biosciences' merger with Quanterix, Welsbach Technology Metals Acquisition's merger with Evolution Metals LLC, and Playa Hotels & Resorts' merger with Hyatt Hotels Corporation.GlobeNewswire Inc. · Apr 28, 2025

$TOCKHOLDER ALERT: The M&A Class Action Firm Urges Shareholders of FNA, BECN, QTRX, PLYA to Take ActionThe M&A Class Action Firm is investigating proposed mergers involving Paragon 28, Inc. (FNA), Beacon Roofing Supply, Inc. (BECN), Quanterix Corporation (QTRX), and Playa Hotels & Resorts N.V. (PLYA), urging shareholders to take action.GlobeNewswire Inc. · Apr 2, 2025

Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your RightsQuanterix Corporation (NASDAQ: QTRX) announced that its previously issued financial statements should no longer be relied upon, causing its stock price to drop 18.3%. The Rosen Law Firm is investigating potential securities claims on behalf of shareholders.GlobeNewswire Inc. · Feb 18, 2025

$TOCKHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – EVGR, QTRX, RKDA, EBTCThe M&A Class Action Firm is investigating the proposed mergers of Evergreen Corporation, Quanterix Corporation, Arcadia Biosciences, and Enterprise Bancorp, providing information for shareholders.GlobeNewswire Inc. · Feb 14, 2025

Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your RightsQuanterix Corporation (NASDAQ: QTRX) announced that its previously issued financial statements should no longer be relied upon, causing its stock price to drop 18.3%. The Rosen Law Firm is investigating potential securities claims on behalf of Quanterix shareholders.GlobeNewswire Inc. · Feb 14, 2025

Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your RightsQuanterix Corporation (NASDAQ: QTRX) announced that its previously issued financial statements should no longer be relied upon, causing its stock price to drop 18.3%. The Rosen Law Firm is investigating potential securities claims on behalf of shareholders.GlobeNewswire Inc. · Feb 12, 2025

to start trading

QT

QTRXQuanterix Corporation Common Stock

QTRX

Pay with—

Available Balance0.00

Your PositionYou don't own any QTRX yet.

Related Tickers

Earnings